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Abstract
Background:  Nerve growth factor and neurotrophin-3 are involved in the development of
sympathetic neurons; however, whether brain derived neurotrophic factor also plays a role is not
known. The purpose of this study was to determine whether BDNF and its receptor, TrkB, are
expressed during the development of paravertebral sympathetic ganglia in vivo and to determine the
effect of BDNF in vitro.
Results: As neural crest cells coalesce to form sympathetic ganglia, TrkB-positive cells are seen in
both chicken and mouse embryos. In chicken embryos, TrkB-expressing cells first appear at
Hamburger-Hamilton Stage (St) 27 and they co-express HNK-1, confirming that they are migrating
neural crest cells. The TrkB-positive cells lack neural markers at this stage; however, they migrate
with other neurally differentiating cells that are TrkA and TrkC-positive. By St. 29/30, TrkB-positive
cells begin to express the neural specific markers Hu C/D and Islet-1; eventually, all TrkB positive
cells commence neural differentiation. By St. 34, TrkB and TrkC staining are lost. BDNF transcript
expression parallels that of TrkB. In the mouse, TrkB-positive cells surround newly formed
sympathetic ganglia and a small number of TrkB positive cells that co-express tyrosine hydroxylase
are seen within ganglia between E13.5-15. In cell culture, many cells from St. 29–30 chicken lumbar
sympathetic ganglia express neural markers and are dividing, indicating that they are
sympathoblasts. Sympathoblasts and neurons require both nerve growth factor and neurotrophin-
3 for survival. BDNF increases the number of cells expressing neural markers in culture by
increasing number of cells that incorporate bromodeoxyuridine. In contrast, most TrkB-positive
sympathetic cells in vivo are not actively proliferating between E6–E8.
Conclusion: Developing paravertebral sympathetic ganglia in avian and murine embryos contain a
subpopulation of sympathoblasts that transiently express TrkB and ultimately commence neuronal
differentiation. These TrkB expressing sympathoblasts are not actively dividing in vivo; yet, when
placed in vitro, will divide in response to BDNF. This suggests that the availability of BDNF in vivo
fails to reach a threshold necessary to induce proliferation. We suggest that excess TrkB
stimulation of sympathoblasts in vivo may lead to the genesis of neuroblastoma.
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Background
Neural crest cells destined to become paravertebral sym-
pathetic neurons proliferate and differentiate during
migration and gangliogenesis. In chicken embryos,
migrating neural crest cells express catecholamines at
Hamburger/Hamilton Stage (St.) 19, and these cells form
the primary sympathetic chain dorsolateral to the aorta at
St. 22 (E3.5) [1]. Between St. 23 (E4) and St. 28 (E6),
these cells disperse and undergo a secondary migration to
form the paravertebral sympathetic chain that resides ven-
tral to the spinal cord and dorsal root ganglion [1]. After
ganglia coalesce, sympathoblasts express markers of neu-
ronal differentiation, such as Q211 and tyrosine hydroxy-
lase (TH), at a time when they also incorporate [3H]-
thymidine [2]. Time lapse photography has shown that
cultured E15.5–E16.5 sympathetic neurons from rat
embryos extend axons while they divide [3-5]. Although
proliferation appears to be an important process to
expand the sympathetic neuron population during differ-
entiation, the mechanisms that guide sympathoblast pro-
liferation have not been identified.
The development of sympathetic neurons is guided by
neurotrophins. Neurotrophin-3 (NT-3) binds to its recep-
tor, TrkC, to promote the survival of cultured sympathob-
lasts from early lumbar paravertebral ganglia [6]. Nerve
growth factor (NGF) signals through its receptor, TrkA, to
promote the survival of sympathetic neurons upon target
innervation [7]. There are severe sympathetic defects in
the superior cervical ganglion of individual NT-3 and NGF
knockout mice [8-10]. Furthermore, there is no additional
cell death in the superior cervical ganglion of NT-3 and
NGF double knockout mouse embryos, suggesting that all
of the neurons are dependent on both neurotrophins for
survival [11]. There is also an increase in sympathetic neu-
ron cell death in TrkA knockout mice [12]. However, in
TrkB and BDNF knockout mice, there is no apparent phe-
notype in the superior cervical ganglion, and there is little
evidence that TrkB or BDNF is expressed in sympathetic
ganglia. Thus, it is generally thought that TrkB and BDNF
have little or no roles in guiding the development of sym-
pathetic neurons.
In addition to their developmental functions, neuro-
trophin receptors regulate cell behavior in neuroblast-
oma, a tumor found in sympathetic ganglia and adrenal
medulla. Tumors that express TrkA often spontaneously
regress, while those that express TrkB and its ligand, brain-
derived neurotrophic factor (BDNF), grow aggressively,
are invasive, and fail to respond to chemotherapeutic
agents [13]. The presence of TrkA in neuroblastoma
tumors is consistent with its expression in developing
sympathetic neurons, and suggests that regressive neurob-
lastoma tumors arise from early sympathetic neurons that
express TrkA. The function of TrkB in early sympathetic
development is unknown, which makes understanding
the etiology of aggressive neuroblastoma tumors difficult.
Based on its function in neuroblastoma tumors, we
hypothesize that BDNF and TrkB expression in differenti-
ating sympathoblasts is responsible for expanding the
neuronal population through proliferation.
We sought to determine whether BDNF and TrkB are
involved in sympathetic development. We report that dur-
ing early embryonic development, TrkB is expressed in a
subset of differentiating sympathoblasts in both avian
and murine embryos. We also find that BDNF promotes
the proliferation of TrkB-positive sympathoblasts in cell
culture. However, the majority of TrkB positive cells in
vivo fail to take up bromodeoxyuridine (BrdU) over a 24
hr period, suggesting that endogenous BDNF concentra-
tions do not reach a threshold necessary to stimulate pro-
liferation of sympathoblasts. Shortly after all of the TrkB
positive cells commence neuronal differentiation, TrkB
immunoreactivity is lost. These results suggest that pro-
longed expression and/or activation of TrkB signaling at
these early stages may be an early event triggering the for-
mation of neuroblastoma.
Results
TrkB is expressed during migration of neural crest cells to 
sympathetic ganglia
We first determined whether TrkB is expressed in neural
crest-derived cells in the region ventral to the spinal cord
and dorsal root ganglia where sympathetic ganglia coa-
lesce between Hamburger/Hamilton Stages (St.) 25–28/
29. To identify cells that have commenced neuronal dif-
ferentiation, transverse sections of the lumbar spinal col-
umn region were stained with antibodies against Hu C/D
[14], a neuronal-specific RNA-binding protein, or Islet-1,
a transcription factor found in sympathetic neurons [15].
We found that Hu C/D and Islet-1 are expressed in the
same cells both in vivo and in vitro throughout sympa-
thetic development. In experiments done between St. 25
and 28, Islet-1 staining appeared weaker than Hu C/D
staining, and thus we used Hu C/D to identify differenti-
ating neurons at these stages. At later stages, Islet-1 was
used to facilitate the identification of neurons because of
the nuclear location of its immunoreactivity.
Cells expressing Hu C/D are first detected at St. 25 ventral
to the spinal cord and dorsal root ganglion and lateral to
the dorsal aorta (Figure 1A, 1B). By St. 26, the number of
cells that express Hu C/D in this region increases dramat-
ically (Figure 1C). TrkB-expressing cells first appear at St.
27 in the same region and are adjacent to Hu C/D-positive
cells (Figure 1D, 2A, 2H). TrkB-positive cells co-localize
with a neural crest marker, HNK-1 (Figures 2B, 2C, 2D).
The Hu C/D-positive cells in this region are likely to be
sympathetic neurons, since they appear in the regionBMC Developmental Biology 2007, 7:10 http://www.biomedcentral.com/1471-213X/7/10
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where sympathetic ganglia form and express tyrosine
hydroxylase, a rate-limiting enzyme in the synthesis of
catecholamines (Figures 2E, 2F, 2G). At St. 28/29, the cells
begin to coalesce ventral to the dorsal root ganglion and
the Hu C/D-positive cells and TrkB-positive cells remain
as two separate cell populations (Figure 1E); however,
shortly afterwards, all of the TrkB-positive cells begin to
express Islet-1 (Figure 3B) and Hu C/D (data not shown).
Developmental regulation of TrkA, TrkB, TrkC, and BDNF 
expression
In contrast to TrkB, the other neurotrophin receptors,
TrkA and TrkC, are co-expressed in both Hu C/D-positive
and Hu C/D-negative cells at St. 27 (Figures 2I, 2J). We
find that approximately 30% of the Islet-1-positive cells
express TrkA (Figure 3A), while 50% express TrkB (Figure
3B) and 100% express TrkC (Figure 3C) at St. 29/30
(E6.5). Thus, all developing neurons express TrkC in com-
bination with either TrkA or TrkB. By St. 31 (E7), the
number of TrkA-positive, Islet-1-positive cells increases to
100% (Figure 3D) and immunoreactivities for both TrkB
and TrkC appear dispersed (Figure 3E, 3F). By St. 34 (E8),
TrkA expression is well-sustained (Figure 3G) and TrkB
and TrkC immunoreactivities are lost (Figure 3H, 3I). We
also examined the early development of murine sympa-
thetic ganglia (Figure 4). At E13, the newly formed lumbar
sympathetic ganglia can be observed ventral to the spinal
cord and notochord by their staining for Hu C/D and TH
(Figure 4A). TrkB-positive cells can be seen surrounding
developing ganglia, as well as in occasional cells within
the ganglia (Figure 4C, D). These TrkB-positive cells
within the ganglia co-express TH and are seen at a fre-
quency of 1–2 cells per section starting at E13 (Figure 4A–
D) and are still present at E15.5 (data not shown).
In neuroblastoma cells, BDNF is co-expressed with TrkB,
suggesting that autocrine stimulation is a means by which
proliferation is sustained in the transformed cells. To test
whether BDNF, the ligand for TrkB, was present in embry-
onic chick sympathetic ganglia, we used quantitative real-
time PCR with TaqMan probes to determine the relative
abundance of BDNF transcripts in total RNA extracted
from lumbar sympathetic ganglia at St. 29/30 (E6.5), St.
31 (E7), St. 34 (E8), and E9. BDNF expression within the
ganglia parallels that of TrkB: BDNF mRNA expression
levels are highest at St 29/30 (E6.5), and these levels
decrease 2-fold at St. 31 (E7) and St. 34 (E8; Figure 5). By
TrkB-expressing cells surround neurons during sympathetic gangliogenesis Figure 1
TrkB-expressing cells surround neurons during sympathetic gangliogenesis. Chicken embryos at St. 25, 26, 27, and 
28/29 were sectioned through the trunk and the patterns of Hu C/D-(white or red) and TrkB-(green) immunoreactivity were 
determined. (A) Low and (B) high power images demonstrating that at St. 25 (early E5) very few Hu C/D-positive cells are 
found in the region where sympathetic ganglia form, ventral to the spinal cord (SC) and dorsal root ganglion (DRG) and lateral 
to the dorsal aorta (DA). (C) At St. 26, migrating Hu C/D-positive cells are present, but TrkB is still not expressed. (D) At St. 
27, TrkB-positive cells "cluster" around Hu C/D-expressing cells, although TrkB is not expressed in the neuronal cells. (E) Sym-
pathetic ganglia coalesce at St. 28/29, and TrkB-expressing cells remain adjacent to Hu C/D expressing cells. The box in (A) 
indicates the region where we obtained high power images. Calibration bars: Low power image: 200 µ; high power images: 20 
µ.BMC Developmental Biology 2007, 7:10 http://www.biomedcentral.com/1471-213X/7/10
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E9, BDNF levels are 7 times lower than at St. 29/30 (E6.5;
Figure 5).
NT3 and NGF promote survival of differentiating 
sympathetic neurons in culture
To determine the effect of neurotrophins, we cultured
cells dispersed from lumbar sympathetic ganglia at St. 29/
30 (E6.5) because, at this stage, ganglion formation is
complete, the number of TrkA-, TrkB-, and TrkC-positive
cells have peaked, and all Trk-expressing cells have initi-
ated neural differentiation. First, we identified markers
expressed by acutely isolated cells. As shown in Table 1,
80–91% of the cells are p75 neurotrophin receptor
(NTR)-positive, indicating that most of the cells are neural
crest-derived and little mesenchymal contamination is
introduced by the isolation procedure. In addition, 28–
33% of the cultured cells express the neural marker Hu C/
D. Approximately half of these Hu C/D-positive cells
express TrkB. Conversely, all of the TrkB positive cells
express Hu C/D. These TrkB-positive cells comprise
approximately 14–17% of the total cell population.
We then determined how many of the acutely isolated
cells were proliferating by incubating them for 12 hrs in
BrdU-containing medium. For these experiments, we
identified differentiating neurons with the transcription
factor Islet-1 because this marker labels nuclei, thus it co
localizes with any BrdU that has been incorporated into
the DNA, allowing us to determine whether the cell had
undergone S-phase of the cell cycle. After 12 hrs in BrdU,
59% of Islet-1-positive nuclei stain for BrdU immunoreac-
tivity. Thus, cultures of St. 29/30 sympathetic ganglia con-
tain many cells that proliferate while exhibiting markers
of neuronal differentiation, confirming previous observa-
tions [2]. We call these dividing neuronal precursors sym-
pathoblasts. The remaining non-BrdU incorporating,
Islet-1 positive cells are likely to be post mitotic neurons.
Finally, we determined the trophic requirements of St. 29/
30 (E6.5) sympathetic neurons and sympathoblasts. We
monitored cultures over a three day period after plating
and counted the number of phase bright cells with neur-
ites, a morphological feature of both neurons and sym-
TrkB-expressing neural crest cells migrate with sympathetic neurons at stage 27, or late E5 Figure 2
TrkB-expressing neural crest cells migrate with sympathetic neurons at stage 27, or late E5. (A) Transverse sec-
tion of St. 27 (late E5) chick embryo spinal column region. At this stage, a stream of Hu C/D-positive cells (white) and TrkB-
positive cells (green) are found in the region surrounding the dorsal aorta (DA) and ventral to the neural tube (NT), dorsal 
root ganglion (DRG), and notochord (NC). (B, C, D) St. 27 sections stained for TrkB (green) and a marker of neural crest cells, 
HNK-1 (red). In migrating clusters of TrkB-positive cells, HNK-1 is co-expressed. (E, F, G) St. 27 sections stained for Hu C/D 
(green) and tyrosine hydroxylase (red). All of the migrating neurons and some of the surrounding cells express tyrosine 
hydroxylase. (H) TrkB (green) is only expressed in cells adjacent to Hu C/D-positive cells (red), (I, J) TrkA and TrkC (both 
green) are expressed in both Hu C/D-positive (red) migrating cells and in surrounding cells. The box in (A) indicates the region 
where we obtained high power images. Calibration bars: Low power image: 200 µ; high power images: 20 µ.BMC Developmental Biology 2007, 7:10 http://www.biomedcentral.com/1471-213X/7/10
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Developmental regulation of Trk receptors in sympathetic ganglia Figure 3
Developmental regulation of Trk receptors in sympathetic ganglia. Transverse sections of St 29/30 (E6.5), St. 31 
(E7), and St. 34 (E8) sympathetic ganglia were labeled for Islet-1 (red) and TrkA, TrkB, or TrkC (green). The number of Islet-1-
positive cells that express TrkA increases between St. 29/30 (E6.5) and St. 31 (E7), and all of the neurons express TrkA at St. 
34 (E8) (A, D, G). Islet-1 positive cells express TrkB and TrkC at St. 29/30 (E6.5) (B, C). TrkB and TrkC expression appeared 
dispersed at St. 31 (E7) (E, F), and expression was no longer detectable at St. 34 (E8) (H, I). Calibration bar: 20 µ.BMC Developmental Biology 2007, 7:10 http://www.biomedcentral.com/1471-213X/7/10
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pathoblasts. In the absence of trophic factors, more than
2/3 of the cells die by 24 hours in culture and BDNF, NT-
3, or NGF alone is not sufficient to promote survival (Fig-
ure 6). However, NGF together with NT-3 supports the
survival of a significantly larger number of cells (Figure 6).
For the subsequent experiments, all neurons were cul-
tured with 25 ng/ml NT-3 and 1 µg/ml 7S NGF to opti-
mize survival.
BDNF promotes proliferation of TrkB-positive 
sympathetic neurons in culture
To determine the effects of BDNF, cultures of cells from St.
29/30 (E6.5) sympathetic ganglia were supplemented
with 200 ng/ml BDNF and the number of neurons and
sympathoblasts were counted at 24, 48, and 72 hours
using phase microscopy (Figure 7A). A 1.6-fold increase in
the number of neurons due to BDNF is observed by 24
hours and this number does not increase further at 48 or
72 hours. This effect of BDNF is concentration-dependent
with an EC50 of 75 ng/ml (Figure 7B).
To test whether the increase in the number of neurons and
sympathoblasts caused by BDNF is due to the differentia-
tion of pluripotent neural crest cells, we quantified the
effects of BDNF on the number of neurally differentiating
cells (Hu C/D-positive) versus the number of non-neuro-
nal cells (Hu C/D-negative) after identifying all neural
crest-derived cells by staining for p75NTR in St. 29/30
(E6.5) cultures. If BDNF increases the number of neurons
and sympathoblasts by inducing a non-neuronal cell to
express Hu C/D, then we expected that the total cell
number would remain the same and that there would be
a decrease in the number of non-neuronal cells as well as
a corresponding increase in the number of neurons. After
24 hours, BDNF significantly increases the number of
p75NTR-positive cells as well as the number of Hu C/D-
positive cells (Figure 8A). However, there was no statisti-
cally significant change in the number of non-neuronal
cells. Thus, it is unlikely that BDNF increases the number
of neurons and sympathoblasts by inducing differentia-
tion of non-neuronal cells.
To determine whether the increase in the total number of
neurons and sympathoblasts is caused by BDNF-induced
proliferation, control and BDNF-treated sympathetic cul-
tures were exposed to BrdU for 12 hours after plating, and
the number of cells that incorporated BrdU into their
DNA was determined after 24 hours in culture. Even in the
control condition, a number of cells in the culture are
dividing, giving a high baseline of BrdU incorporation
(Figure 8B). When BDNF is added, the total number of
BrdU positive cells increases approximately 1.6-fold (Fig-
A subpopulation of cells in developing mouse sympathetic ganglia expresses TrkB Figure 4
A subpopulation of cells in developing mouse sympathetic ganglia expresses TrkB. (A) Transverse sections of 
E13.5 mouse embryos were cut and stained for TH (red) and Hu C/D (green) to locate developing ganglia. The ganglion shown 
in the box is shown at higher magnification in the inset. Different subsets of cells express TH, Hu C/D, or both markers. Sec-
tions taken from another ganglion stained with (B) TH (green), (C) TrkB (red), (D) Hoechst dye, and the overlay of all three 
photos. Arrow points to a cell that co-expresses TH and TrkB.BMC Developmental Biology 2007, 7:10 http://www.biomedcentral.com/1471-213X/7/10
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ure 8B). This BDNF-induced increase in the total number
of BrdU positive cells occurs in sympathoblasts because
the number of Islet-1-positive nuclei from control cultures
that label with BrdU is 268 ± 59 and BDNF treatment
raises this number to 424 ± 80, which corresponds to an
increase of 1.6-fold. This accounts for the 1.6-fold increase
in total neuron number and total BrdU-positive cells
described above. We then confirmed that BDNF acts on
TrkB-positive cells: BDNF increases the number of TrkB-
expressing cells that incorporate BrdU 2.6 – 4-fold over
control (Table 2) and it also increases the overall number
of TrkB-positive cells 2 – 2.5-fold over control (Table 2).
BDNF does not increase the number of BrdU-positive,
TrkB-negative cells or the overall number of TrkB-negative
cells (Table 2). In further support that BDNF acts directly
on TrkB-expressing cells, an antibody directed against the
extracellular domain of TrkB completely prevents the
effect of BDNF in promoting proliferation of TrkB-posi-
tive, but not TrkB-negative cells (compare Figure 9A to
9B). Thus, the effect of BDNF is restricted to the popula-
tion that expresses TrkB, which are developing sym-
pathoblasts.
To determine whether TrkB-positive cells are actively pro-
liferating in vivo, embryos were injected with BrdU at St.
27 and harvested at St. 29, approximately 24 hrs later. The
majority (85–90%) of TrkB-positive cells do not incorpo-
rate BrdU into their nuclei under basal conditions in vivo
(Figure 10), although a few TrkB positive cells with
labeled nuclei could be observed (arrows). This contrasts
with our observation that 71–76% of TrkB-positive cells
St. 29/30 (E6.5) Sympathetic neurons require NT3 and NGF  for survival Figure 6
St. 29/30 (E6.5) Sympathetic neurons require NT3 
and NGF for survival. St. 29/30 (E6.5) sympathetic ganglia 
were dissociated and sympathetic neurons were cultured as 
described in Methods. The cells were treated without neuro-
trophins (closed square), or with NT3 alone (open circle), 
NGF alone (closed triangle), or NT3 and NGF (closed dia-
mond). The number of neurons in the same well was 
counted each day to assess survival. The neurons survive 
when cultured with both NT3 and NGF. Data represent 
mean ± SEM from three independent experiments. *Denotes 
statistical significance (p < 0.05), Two-way ANOVA.
Table 1: p75 NTR and Hu C/D Expression in Acutely Isolated Cells from St. 29/30 (E6.5) Sympathetic Ganglia
Experiment 1 (mean values; n = 3) Experiment 2 (mean values; n = 3)
p75NTR (% of total) 1974.3 +/- 368 (91%) 2128.7 +/- 490 (80%)
Hu C/D (% of total) 719.7 +/- 137 (33%) 751 +/- 47 (28%)
Total Number 2177.7 +/- 381 2637 +/- 701
Cells isolated from dispersed St 29/30 (E6.5) lumbar sympathetic ganglia were plated onto poly-lysine and laminin coated cover slips and allowed to 
attach for 2 hrs. Cover slips were then fixed and stained for p75 NTR and Hu C/D using double immunofluorescence. P75 NTR marks all cells 
derived from the neural crest, regardless of their state of differentiation. Hu C/D is a neural-specific RNA binding protein that is an early marker of 
neural differentiation. Each experiment is a separate plating and 3 cover slips were counted for each experiment.
BDNF mRNA expression is developmentally regulated in  embryonic sympathetic ganglia Figure 5
BDNF mRNA expression is developmentally regu-
lated in embryonic sympathetic ganglia. Lumbar sym-
pathetic ganglia were removed from chick embryos at St. 29/
30 (E6.5), St. 31 (E7), St. 34 (E8), and E9 and rapidly frozen 
on dry ice. RNA was isolated and cDNA was reverse-tran-
scribed using oligo-dT. Real-time PCR amplification for 
chicken BDNF was performed using TaqMan probes and 
normalizing target values to the constitutively expressed 
RNA encoding chick ribosomal binding protein S-17 (Chrps). 
BDNF levels are highest at St. 29/30 (E6.5) and levels steadily 
decline at the later stages of development, paralleling the 
expression pattern of TrkB. Data represent the mean ± SEM 
from triplicate samples. Similar results were obtained in two 
separate experiments. *Denotes statistical significance (p < 
0.05), one-way ANOVA.BMC Developmental Biology 2007, 7:10 http://www.biomedcentral.com/1471-213X/7/10
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BDNF increases the total number of differentiating neurons  by inducing proliferation Figure 8
BDNF increases the total number of differentiating 
neurons by inducing proliferation. Cells from St. 29/30 
(E6.5) lumbar sympathetic ganglia were cultured in control 
medium (white bars) or control medium containing 200 ng/
ml BDNF (dark bars) for 24 hrs, then fixed and stained with 
anti-p75NTR and anti-Hu C/D. BDNF increases the total 
number of p75NTR-positive cells as well as the total number 
of neuronal (Hu C/D+), but not non-neuronal (Hu C/D-) 
cells. Data represent mean ± SEM of three cover slips for 
each condition. *Denotes statistical significance (p < 0.05), 
Student's t-test. (B) Cells were labeled with BrdU for the 
first 12 hours in culture, then fixed and stained for BrdU and 
Hoechst dye 24 hrs after plating. BDNF increases the 
number of BrdU-positive cells compared to control. Data 
represent mean ± SEM from six independent experiments. 
*Denotes statistical significance (p < 0.05, Students' t-test).
BDNF increases the number of cells with neuronal morphol- ogy in cultures of dispersed St. 29/30 (E6.5) sympathetic gan- glia Figure 7
BDNF increases the number of cells with neuronal 
morphology in cultures of dispersed St. 29/30 (E6.5) 
sympathetic ganglia. (A) Cells from St. 29/30 (E6.5) lum-
bar sympathetic ganglia were cultured in control medium 
(closed squares) or control medium containing 200 ng/ml 
BDNF (closed diamonds) and the number of cells with neur-
ites longer than two cell body diameters was scored under 
phase contrast optics at 24, 48, and 72 hours. A 1.6 fold 
increase in the number of neurons at each time point was 
seen with BDNF. Data represent mean ± SEM of six wells 
from two independent platings. *Denotes statistical signifi-
cance (p < 0.05), Two-way ANOVA. (B) Cells from St 29/30 
(E6.5) sympathetic ganglia were cultured with increasing con-
centrations of BDNF. The number of neurons was counted 
at the time BDNF was added to the cultures and 24 hours 
after BDNF was added to the cultures. Data correspond to 
the starting number of neurons subtracted from the number 
of neurons counted at 24 hours. Data represent the mean ± 
SEM of six wells from two independent platings.BMC Developmental Biology 2007, 7:10 http://www.biomedcentral.com/1471-213X/7/10
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incorporate BrdU in culture after treatment with BDNF
(Table 2), suggesting that endogenous BDNF does not
achieve a threshold sufficient to support a high level of
sympathoblast proliferation in vivo.
Discussion
We report that the neurotrophin receptor TrkB is
expressed in a subset of embryonic sympathoblasts during
the early development of lumbar paravertebral sympa-
thetic ganglia in chicken and mouse embryos. In the
chicken, TrkB expression is transient, and completely lost
by St 34 (E8). Since BDNF induces the proliferation of
sympathoblasts in cell culture, yet in vivo there is little pro-
liferation observed in TrkB-positive cells in nascent gan-
glia, we propose that if TrkB activation becomes
unregulated by excess BDNF or constitutive phosphoryla-
tion of TrkB [16], this transient population of TrkB-posi-
tive sympathoblasts may trigger the genesis of
neuroblastoma, a childhood tumor found in the paraver-
tebral chain and adrenal medulla.
The two populations of sympathoblasts that we observe
support previous findings of heterogeneity among devel-
oping sympathetic neurons and neural crest cells. Early
sympathetic ganglia contain at least two subpopulations:
early differentiating neurons that lack TrkB expression and
express TrkA and TrkC, and late differentiating sym-
pathoblasts that express TrkB. Explant cultures of sympa-
thetic ganglia from E16 chick embryos give rise to two
neuronal populations: one that remains close to the
explant, and one that migrates away from the explant [1].
In addition, early neuronal subpopulations have been
observed in cultures of neural crest cells from St. 13/14
quail embryos as evidenced by the expression of neuronal
cell type-specific gangliosides [17]. Perhaps these different
subpopulations will ultimately give rise to the two neuro-
chemically distinct populations found in lumbar sympa-
thetic ganglia: the noradrenergic, NPY-containing
neurons that innervate internal organs and enteric ganglia
and the cholinergic, VIP-containing neurons that inner-
vate vasculature in the hind limbs.
The effects of BDNF and TrkB deletion and over expres-
sion have been studied on superior cervical ganglion and
preganglionic neurons in thoracic segments of the spinal
column, but not on paravertebral sympathetic neurons. In
the superior cervical ganglion, an increase in the number
of neurons of BDNF null mice is likely due to apoptosis
induced by BDNF via p75NTR [18]. In contrast, the
responses of paravertebral sympathetic neurons to BDNF
are complex and subtype dependent. Over expression of
BDNF leads to an increase in the number of noradrenergic
fibers innervating the erector pilli muscles of hair follicles,
while noradrenergic fibers innervating blood vessels were
unaffected [19]. If our results indicating that BDNF pro-
motes proliferation of TrkB-positive sympathoblasts in
the chicken embryo can be extrapolated to the subset of
TrkB-positive sympathoblasts in murine ganglia, then
these TrkB-positive cells may be neurons destined to
innervate the erector pilli. In other studies, TrkB null mice
showed no changes in morphology or cell number in
superior cervical ganglia [12] or in the intermediolateral
column [20]; but this may not be predictive of a pheno-
type in the lumbar paravertebral chain. It is thus possible
that BDNF/TrkB signaling could play a specific role in
other regions of the paravertebral sympathetic chain, such
as the lumbar region. However, if TrkB-positive cells are
not normally actively proliferating in vivo, then it would
not be surprising that the development of the paraverte-
bral sympathetic chain is not disrupted in TrkB or BDNF
Table 2: Effects of BDNF on BrdU Incorporation in TrkB-Expressing Cells from St. 29/30 (E6.5) Sympathetic Cultures
Control BDNF Fold Increase
Experiment 1:
BrdU+/TrkB+ 219 ± 34 845* ± 95 4×
TrkB+ 438 ± 55 1111* ± 153 2.5×
BrdU+/TrkB- 258 ± 36 187 ± 14 No change
TrkB- 962 ± 42 900 ± 109 No change
Experiment 2:
BrdU+/TrkB+ 258 ± 54 673* ± 64 2.6×
TrkB+ 508 ± 77 947* ± 126 2×
BrdU+/TrkB- 211 ± 14 180 ± 48 No change
TrkB- 892 ± 75 834 ± 105 No change
Cultures of St 29/30 (E6.5) lumbar sympathetic ganglia were exposed to 10 µM BrdU for 12 hrs, followed by complete medium lacking BrdU. 
Twenty-four hrs after plating, cells were fixed and stained for TrkB and BrdU using double immunofluorescence. All nuclei were also stained with 
Hoechst dye. The total number of BrdU+, TrkB+ and BrdU+, TrkB-cells was scored by counting 10 fields of view using epifluorescence optics. In 
experiments 1 and 2 respectively, 76% and 71% of the TrkB+ cells incorporate BrdU in response to BDNF. Each experiment represents the mean 
+/- SEM of 3 cover slips from two independent platings.BMC Developmental Biology 2007, 7:10 http://www.biomedcentral.com/1471-213X/7/10
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null mice. It may be more informative to examine mice
that over express BDNF on a promoter that targets expres-
sion to embryonic lumbar ganglia. Unfortunately, such
mice do not exist.
Our findings that the St. 29/30 (E6.5) sympathoblasts are
dependent on both NT-3 and NGF for survival in culture
are consistent with previous work on mouse sympathob-
lasts from the superior cervical ganglion [11]. In these
studies, NT-3 and NGF deletion separately led to a
decrease in the number of sympathetic neurons at E17.5
compared to control. Deletion of both NT-3 and NGF
together did not enhance cell death. In contrast, cultured
rat superior cervical ganglion sympathetic neurons
respond to NT-3 at E14.5 and then to NGF at E19.5,
although time points in between were not analyzed [6].
In addition to promoting survival, NT-3, NGF, and BDNF
also induce proliferation of various neuronal precursors at
different stages of development. NT-3 can promote the
incorporation of [3H]-thymidine into cultured quail neu-
ral crest cells from the trunk region [21,22], Later in rat
sympathetic development, NT-3 supports survival of neu-
rons, but does not promote proliferation [6], which is
consistent with our results. NGF promotes an increase in
BrdU incorporation from 25% to 35% in the DRG cervical
segment 2 in the chick embryo [23]. In chicken embryos
that are treated with NGF in ovo at St. 18 and 21, there is
an increase in BrdU uptake after formation of the primary
sympathetic chain at St. 23 [24]. Since NGF does not
appear to affect proliferation of St. 29/30 (E6.5) chick
The majority of TrkB-positive cells in St. 29 sympathetic gan- glia do not proliferate under basal conditions in vivo Figure 10
The majority of TrkB-positive cells in St. 29 sympa-
thetic ganglia do not proliferate under basal condi-
tions in vivo. St. 27 embryos were injected with 25 µg BrdU 
and embryos were harvested at St. 29. Transverse sections 
of sympathetic ganglia prepared to determine whether TrkB-
positive cells (red) in sympathetic ganglia positively-labeled 
for BrdU. The majority of TrkB-positive cells do not prolifer-
ate under basal conditions in vivo. Arrows indicate proliferat-
ing cells. Calibration bars = 20 µ.
The effects of BDNF are specific to TrkB expressing cells Figure 9
The effects of BDNF are specific to TrkB expressing 
cells. Cells from dispersed St 29/30 (E6.5) lumbar sympa-
thetic ganglia were cultured in control medium or medium 
supplemented with 200 ng/ml BDNF together with 1:1000 
rabbit anti-TrkB extracellular domain (dark bars), 1:1000 
non-immune rabbit serum (white bars) or no addition 
(hatched bars). All cultures were pulsed for 12 hrs with 
BrdU, and then harvested 24 hrs after plating, fixed, and 
stained with anti-BrdU, anti-TrkB, and Hoechst dye. (A) 
BDNF induces a significant increase in the number of TrkB+, 
BrdU+ cells that are blocked by the antiserum against TrkB, 
but not by the non-immune rabbit serum. (B) In contrast, 
there is no increase in the number of TrkB-cells, and the 
antisera have no effect additional effects. The values in both 
(A) and (B) represent the mean ± SEM of 6 cover slips from 
two independent platings.BMC Developmental Biology 2007, 7:10 http://www.biomedcentral.com/1471-213X/7/10
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sympathoblasts, NGF may only promote proliferation in
primary, but not secondary chain sympathoblasts. Motor
neuron progenitors in the ventral neural tube from the
chick embryo express TrkB and when ventral neural tube
explants are treated with BDNF, there is an increase in the
number of motor neurons produced and BrdU incorpora-
tion [25]. BDNF also promotes the proliferation of cul-
tured neuroblastoma cells [13]. Taken together, these
results are consistent with our findings that NT-3 and NGF
do not promote proliferation of St. 29/30 (E6.5) sym-
pathoblasts, and support the assertion that BDNF pro-
motes proliferation of TrkB-positive sympathoblasts in
culture.
Our observations suggest a transient function of TrkB dur-
ing early sympathetic development in supporting prolifer-
ation of this early subpopulation of sympathoblasts.
However, the in vivo labeling suggests that only a minority
(10–20%) of this population is dividing during the win-
dow that TrkB is expressed. In light of the very strong pro-
liferative effect produced in cell culture, these TrkB
expressing cells could respond more strongly if endog-
enous BDNF rises to higher levels, or if the mechanism
that down regulates TrkB expression becomes nonfunc-
tional. Such events could trigger an early proliferative
event that leads to a cascade of changes that initiates trans-
formation of cells to neuroblastoma. Thus, these early
TrkB expressing cells help solve the puzzle as to why TrkB
is expressed in aggressive and invasive forms of neuroblas-
toma, particularly because BDNF induces cultured neu-
roblastoma cells to become more proliferative, invasive,
angiogenic, and resistant to chemotherapeutic reagents
than untreated cultures [13]. Future studies will deter-
mine whether constitutive expression of BDNF and TrkB
in the chick embryo sustains proliferation of differentiat-
ing sympathoblasts.
Conclusion
We have identified a time point during development
when differentiating lumbar sympathetic neurons tran-
siently express TrkB and proliferate in response to high
concentrations of BDNF in culture. These studies suggest
that elevated BDNF expression above basal levels and sig-
naling through TrkB may be a mechanism that contributes
to the onset of neuroblastoma. A further understanding of
the two populations of sympathetic neurons and the fate
of the TrkB-positive cells will provide additional insight
into the development of paravertebral sympathetic gan-
glia and the genesis of neuroblastoma.
Methods
Preparation of tissue for immunohistochemistry
The lumbar spinal column and surrounding tissues were
dissected from chicken embryos at the indicated stages
and placed in Zamboni's fixative (4% (w/v) paraformal-
dehyde, 15% (v/v) picric acid in 0.1 M sodium phosphate
buffer, pH 7.4) for two hours at room temperature. Mouse
embryos at 13–15 days post-coitus were collected accord-
ing to an IACUC-approved protocol to Dr. L. Sherman at
the Oregon Health and Science University. The mouse
embryos were immersion-fixed in Zamboni's fixative
overnight at 4 degrees C then washed with phosphate
buffered saline (PBS; 130 mM NaCl, 20 mM sodium
phosphate buffer, pH 7.4). Fixed tissues were equilibrated
in 30% sucrose in 1× phosphate-buffered saline (PBS).
Fixed mouse embryos were shipped to Vermont in
sucrose. Transverse 30 µM sections of the spinal columns
were cut at on a Microm HM cryostat (knife temperature:
16°C; object temperature: 23°C) and collected on Super-
frost Plus slides (Fisher). Sections were dried at room tem-
perature, washed in 1× PBS and incubated overnight in
blocking buffer (1× PBS consisting of 10% (v/v) heat-
inactivated horse serum (Invitrogen/Gibco), 0.5% Triton
X-100 (Sigma), and 0.1% sodium azide (Fisher)).
Immunohistochemistry
Sections were incubated with primary antibodies over-
night at 4°C, followed by incubation with secondary anti-
bodies for 2 hours at room temperature. Primary
antibodies used were: rabbit anti-p75 (1:1500, generous
gift from Louis Reichardt, UCSF [26]), mouse IgG2b anti-
Hu C/D, (1:250, Molecular Probes); mouse IgG1 anti-
Islet-1, (1:10, Developmental Studies Hybridoma Bank);
rabbit anti-chicken TrkA (1:500); rabbit anti-chicken TrkB
(1:500); rabbit anti-chicken TrkC (1:500) (all Trk anti-
bodies were generous gifts of Dr. Louis Reichardt, UCSF
[26-28]); mouse anti-HNK-1 (1:50, Developmental Stud-
ies Hybridoma Bank); mouse IgG2a anti-tyrosine hydroxy-
lase (1:10, Developmental Studies Hybridoma Bank),
sheep anti-BrdU (1:100, Biodesign International), rabbit
anti-tyrosine hydroxylase (1:100, Chemicon), and goat
anti-TrkB (1:1000, R&D Systems). Immunofluorescence
was imaged using a Nikon C1 confocal mounted on a
Nikon Eclipse E800 microscope with a 10× Plan Apo (NA
0.785) air objective or a 60× Plan Apo (NA 1.4) oil objec-
tive lens, E7-C1 software, and UV, Argon, and He/Ne
lasers exciting at 408, 488, and 543 nm and emitting at
404 500–530, and 555–615 nm, respectively. A Nikon
Eclipse E800 microscope in the nearby COBRE Molecular/
Cellular Core Facility was used for counting immunofluo-
rescent cells at 200× using epifluorescence optics.
RNA Extraction/cDNA synthesis
Sympathetic ganglia were removed from chick embryos
and RNA was isolated using TriReagent (Molecular
Research Center), an acidified guanidinium with phenol
extraction method [29]. RNA was transcribed to cDNA
using oligo-dT with Superscript II Reverse Transcriptase
(Invitrogen) at 42°C for 1 hour.BMC Developmental Biology 2007, 7:10 http://www.biomedcentral.com/1471-213X/7/10
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Real-time PCR
Relative RNA levels were determined using quantitative
real-time PCR with an ABI 7500 Fast Real Time PCR Sys-
tem. TaqMan probes were used to quantify the progres-
sion of the PCR reaction and reactions were normalized
using the constitutively expressed gene chick ribosomal
binding protein s17 (CHRPS). The sequences were used
for primer/probes sets: for BDNF: forward: 5'-
AGCCCAGTGAGGAAAACAAG-3', reverse: 5'-ACTCCTC-
GAGCAGAAAGAGC-3', probe: 5'-[6-FAM]-TACACATC-
CCGAGTCATGCTGAGCA-[BHQ]-3'; for CHRPS (chick
ribosomal binding protein S-17):
5'AACGACTTCCACACCAACAA3', reverse:
5'CTTCATCAGGTGGGTGACAT3', probe: 5'-[6-FAM]-
CGCCATCATCCCCAGCAAGA [BHQ]-3'. Primers and
probes were synthesized by Operon Technologies, Inc
(Alameda, CA). The primers for BDNF were validated
against primers for CHRPS according to an Applied Bio-
Systems protocol by serially diluting the target cDNA
1:10, determining the cycle threshold (Ct) for each reac-
tion, and plotting the Ct versus log concentration. Slopes
of the resulting lines were calculated and primers were
accepted if their Ct slopes were between -3.2 and -3.4 (a
perfect efficiency of 1.0 yields a slope of -3.3). To analyze
the data, the delta Ct method of relative quantification
was used, where the Ct of Chrps was subtracted from the
Ct of the gene of interest (Delta Ct) and the arbitrary units
of mRNA were expressed as 10000/2^(Delta Ct).
Cell culture
Sympathetic neurons were cultured as previously
described [30] with a few modifications. Sympathetic gan-
glia were removed from the lumbar region of the paraver-
tebral chain of St. 29/30 (E6.5) chick embryos and placed
in Modified Puck's solution with glucose (MPG). The cells
were dissociated by incubation of sympathetic ganglia
with 0.1% trypsin in MPG at 37°C for 10 minutes fol-
lowed by triturating with a fire polished 9" Pasteur
pipette. Cells were then resuspended in Dulbecco's Modi-
fied Eagle Medium (DMEM) consisting of 10% horse
serum, 2% fetal calf serum, and 10 mg/ml penicillin/
streptomycin. For neurotrophin studies, the culture
medium was supplemented with 25 ng/ml NT-3 (R & D
Systems) and 1 µg/ml 7S NGF (Alomone Labs) upon plat-
ing, and 50 ng/ml, 100 ng/ml, or 200 ng/ml BDNF (R &
D Systems) once the cells adhered to the wells. Cells were
plated on poly-D-lysine/laminin coated wells or cover
slips (Fisher) as previously described [30].
Quantification of neurons and sympathoblasts using phase 
microscopy
Embryonic sympathoblasts and neurons are small, phase
bright cells with neurites. The total number of cells with
neurites the length of two cell bodies were counted in 10
non-overlapping fields of view evenly spaced in a grid-like
pattern across the bottom of a well from a 24 well plate at
200× using a Nikon Eclipse TE200 microscope.
BrdU labeling
For in vitro studies, approximately 2 hours after plating
cells from St. 29/30 (E6.5) sympathetic ganglia, cells were
labeled with 10 µM bromodeoxyuridine (BrdU, Sigma)
for 12 hours at 37°C. Following this labeling period, cells
were incubated in complete medium without BrdU for an
additional 10 hrs. Cells were then fixed in Zamboni's fix-
ative for 30 min at room temperature and rinsed with 1×
PBS. For in vivo studies, 25 µg BrdU was injected into the
amnion of chick embryos at St. 27. The cells and sections
were denatured with 2 N HCl at 37°C for 1 hr, and were
then neutralized with 0.1 M borate buffer, pH 8.5, for 10
min at room temperature. Immunochemistry was per-
formed as described above.
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